Last reviewed · How we verify
Systemic apelin infusion
At a glance
| Generic name | Systemic apelin infusion |
|---|---|
| Sponsor | University of Edinburgh |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Investigating the Inotropic Potential of Apelin (NA)
- A Series of Pilot Studies to Evaluate the haemoDynamic and mEtabolic Effects oF apelIn aNd rElaxin (PHASE2)
- Haemodynamic Effects of Apelin Agonists and Antagonists in Man in COPD With Raised Pulmonary Artery Pressures (NA)
- Interaction of Apelin and Angiotensin in the Systemic Circulation (NA)
- Investigating Systemic and Local Vascular Responses to Apelin in the Context of Renin-angiotensin Upregulation (NA)
- Interaction of Apelin and Angiotensin in the Human Forearm Circulation (NA)
- Interaction of Apelin and Angiotensin in the Human Forearm Circulation (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Systemic apelin infusion CI brief — competitive landscape report
- Systemic apelin infusion updates RSS · CI watch RSS
- University of Edinburgh portfolio CI